AKT1 and non-small cell lung carcinoma: Additional analysis of the interactions between target proteins from CRE and their associations with NSCLC revealed several potential targets within cancer pathways, such as resistance to EGFR tyrosine kinase inhibitors, HIF1 Signaling, MAPK, NSCLC, Cancer, PI3K-AKT, and RAS Signaling (Figure 1B).